Cadista Pharmaceuticals Revenue and Competitors

Salisbury, MD USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Cadista Pharmaceuticals's estimated annual revenue is currently $30.6M per year.(i)
  • Cadista Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Cadista Pharmaceuticals has 152 Employees.(i)
  • Cadista Pharmaceuticals grew their employee count by -6% last year.

Cadista Pharmaceuticals's People

NameTitleEmail/Phone
1
Senior Director, MarketingReveal Email/Phone
2
Director, Human ResourcesReveal Email/Phone
3
Associate Director, Manufacturing Science & TechnologyReveal Email/Phone
4
Manager, Regulatory AffairsReveal Email/Phone
5
Procurement & Planning ManagerReveal Email/Phone
6
QA Compliance SpecialistReveal Email/Phone
7
Customer Service CoordinatorReveal Email/Phone
8
Quality Control ChemistReveal Email/Phone
9
Technical WriterReveal Email/Phone
10
Chemist IIlReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M35-3%N/AN/A
#2
$7.2M36-5%N/AN/A
#3
$10.5M52-9%N/AN/A
#4
$344.1M17129%N/AN/A
#5
$27.5M1376%N/AN/A
#6
$107.3M5349%N/AN/A
#7
$12.9M6428%N/AN/A
#8
$31.6M1571%N/AN/A
#9
$31.4M1567%N/AN/A
#10
$11.5M5730%N/AN/A
Add Company

What Is Cadista Pharmaceuticals?

Cadista does more than provide you with the right choice of generic pharmaceutical products at the right price. Cadista provides you with the confidence that comes from working with a company that you can trust and rely on for uncompromising quality, supply, and customer service. Cadista Holdings Inc and its fully owned subsidiary Jubilant Cadista Pharmaceuticals Inc are engaged in the development, manufacture, sale and distribution of prescription generic pharmaceutical products in the United States. Pharmaceutical products, commonly referred to as generics are the pharmaceutical and therapeutic equivalent of brand name drug products and are usually marketed under their established non proprietary drug names, rather than under a brand name. Generic pharmaceuticals contain the same active ingredient and are of the same route of administration, dosage form, strength and indication(s) as brand name pharmaceuticals already approved for use in the Food and Drug Administration “FDA” Cadista focuses on relevant immediate and extended release products utilizing the vertical integration with its ultimate parent company to deliver high value products. The company has maintained a strong presence in the growing generics market.

keywords:N/A

N/A

Total Funding

152

Number of Employees

$30.6M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cadista Pharmaceuticals News

2022-04-17 - Global Multi-Infarct Dementia Market 2022 Trend by ...

Forest Laboratories; Janssen Pharmaceuticals; Novartis Pharmaceutical; Pfizer; Eisai; Ortho-McNeil Pharmaceutical; Takeda; Jubilant Cadista...

2022-04-17 - Montelukast Sodium Market Size, Scope And Forecast ...

... TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, Hetero Labs, Unimark Remedies, Jubilant Cadista, Aamorb Pharmaceuticals.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.6M154-4%N/A
#2
$15M1641%N/A
#3
$18.6M1695%N/A
#4
$7.5M1749%N/A
#5
N/A18124%N/A